Cargando…

Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis

OBJECTIVES: We aimed to comprehensively evaluate the relationship between forkhead box P3 (FOXP3(+)) regulatory T cell (Treg) expression and diffuse large B-cell lymphoma (DLBCL) prognosis and to explore the sources of heterogeneity of the results. DESIGN: Systematic review and meta-analysis. DATA S...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yuping, He, Tingting, Zhang, Liyan, Liu, Qianqian, Yang, Jing, Zhao, Ziru, Yang, Kehu, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454056/
https://www.ncbi.nlm.nih.gov/pubmed/36691128
http://dx.doi.org/10.1136/bmjopen-2021-060659
_version_ 1784785269438808064
author Bai, Yuping
He, Tingting
Zhang, Liyan
Liu, Qianqian
Yang, Jing
Zhao, Ziru
Yang, Kehu
Zhang, Min
author_facet Bai, Yuping
He, Tingting
Zhang, Liyan
Liu, Qianqian
Yang, Jing
Zhao, Ziru
Yang, Kehu
Zhang, Min
author_sort Bai, Yuping
collection PubMed
description OBJECTIVES: We aimed to comprehensively evaluate the relationship between forkhead box P3 (FOXP3(+)) regulatory T cell (Treg) expression and diffuse large B-cell lymphoma (DLBCL) prognosis and to explore the sources of heterogeneity of the results. DESIGN: Systematic review and meta-analysis. DATA SOURCES: We searched the Cochrane Library, PubMed, Embase and Web of Science databases up to 5 December 2021. ELIGIBILITY CRITERIA: We included studies that analysed the prognostic significance of FOXP3(+) Tregs in DLBCL. We included studies reported in Chinese or English that reported HRs and related 95% CIs for prognosis. DATA EXTRACTION AND SYNTHESIS: We extracted data from eligible studies. HRs and 95% CIs were used to assess the prognostic value. RESULTS: Fourteen eligible studies were identified. FOXP3(+) Treg expression was not associated with overall survival (OS) (HR=0.72, 95% CI 0.45 to 1.16) or progression-free survival (HR=0.86, 95% CI 0.54 to 1.38). The three approaches used to measure FOXP3(+) Treg expression (p(interaction)<0.001) may be the source of the heterogeneity of the results. Subgroup analysis found that a higher expression of FOXP3(+) Tregs was associated with better OS in all populations and in Asians when FOXP3(+) Treg expression was measured by the number of positive cells (HR=0.36 (95% CI 0.22 to 0.58) in the former, HR=0.33 (95% CI 0.20 to 0.55) in the latter) or the percentage of positive cells (HR=0.49 (95% CI 0.27 to 0.89) in the former, HR=0.38 (95% CI 0.21 to 0.70) in the latter). However, when measured by the score, inverse results were found (HR=1.56, 95% CI 1.01 to 2.42). CONCLUSIONS: Approaches to measuring FOXP3(+) Treg expression might be the major source of heterogeneity in studies of the prognostic significance of FOXP3(+) Tregs in DLBCL. FOXP3(+) Treg expression might be used to predict the prognosis of patients with DLBCL when FOXP3(+) Treg expression is calculated by the number or the percentage of positive cells, especially in Asian populations.
format Online
Article
Text
id pubmed-9454056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94540562022-09-14 Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis Bai, Yuping He, Tingting Zhang, Liyan Liu, Qianqian Yang, Jing Zhao, Ziru Yang, Kehu Zhang, Min BMJ Open Immunology (Including Allergy) OBJECTIVES: We aimed to comprehensively evaluate the relationship between forkhead box P3 (FOXP3(+)) regulatory T cell (Treg) expression and diffuse large B-cell lymphoma (DLBCL) prognosis and to explore the sources of heterogeneity of the results. DESIGN: Systematic review and meta-analysis. DATA SOURCES: We searched the Cochrane Library, PubMed, Embase and Web of Science databases up to 5 December 2021. ELIGIBILITY CRITERIA: We included studies that analysed the prognostic significance of FOXP3(+) Tregs in DLBCL. We included studies reported in Chinese or English that reported HRs and related 95% CIs for prognosis. DATA EXTRACTION AND SYNTHESIS: We extracted data from eligible studies. HRs and 95% CIs were used to assess the prognostic value. RESULTS: Fourteen eligible studies were identified. FOXP3(+) Treg expression was not associated with overall survival (OS) (HR=0.72, 95% CI 0.45 to 1.16) or progression-free survival (HR=0.86, 95% CI 0.54 to 1.38). The three approaches used to measure FOXP3(+) Treg expression (p(interaction)<0.001) may be the source of the heterogeneity of the results. Subgroup analysis found that a higher expression of FOXP3(+) Tregs was associated with better OS in all populations and in Asians when FOXP3(+) Treg expression was measured by the number of positive cells (HR=0.36 (95% CI 0.22 to 0.58) in the former, HR=0.33 (95% CI 0.20 to 0.55) in the latter) or the percentage of positive cells (HR=0.49 (95% CI 0.27 to 0.89) in the former, HR=0.38 (95% CI 0.21 to 0.70) in the latter). However, when measured by the score, inverse results were found (HR=1.56, 95% CI 1.01 to 2.42). CONCLUSIONS: Approaches to measuring FOXP3(+) Treg expression might be the major source of heterogeneity in studies of the prognostic significance of FOXP3(+) Tregs in DLBCL. FOXP3(+) Treg expression might be used to predict the prognosis of patients with DLBCL when FOXP3(+) Treg expression is calculated by the number or the percentage of positive cells, especially in Asian populations. BMJ Publishing Group 2022-09-06 /pmc/articles/PMC9454056/ /pubmed/36691128 http://dx.doi.org/10.1136/bmjopen-2021-060659 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Immunology (Including Allergy)
Bai, Yuping
He, Tingting
Zhang, Liyan
Liu, Qianqian
Yang, Jing
Zhao, Ziru
Yang, Kehu
Zhang, Min
Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title_full Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title_fullStr Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title_full_unstemmed Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title_short Prognostic value of FOXP3(+) regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
title_sort prognostic value of foxp3(+) regulatory t cells in patients with diffuse large b-cell lymphoma: a systematic review and meta-analysis
topic Immunology (Including Allergy)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454056/
https://www.ncbi.nlm.nih.gov/pubmed/36691128
http://dx.doi.org/10.1136/bmjopen-2021-060659
work_keys_str_mv AT baiyuping prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT hetingting prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT zhangliyan prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT liuqianqian prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT yangjing prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT zhaoziru prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT yangkehu prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis
AT zhangmin prognosticvalueoffoxp3regulatorytcellsinpatientswithdiffuselargebcelllymphomaasystematicreviewandmetaanalysis